Cerebral venous sinus thrombosis secondary prevention

	Cerebral venous sinus thrombosis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Epidemiology and Demographics
Risk Factors
Differentiating Cerebral venous sinus thrombosis from other Diseases
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Cerebral venous sinus thrombosis secondary prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Cerebral venous sinus thrombosis secondary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Cerebral venous sinus thrombosis secondary prevention
CDC on Cerebral venous sinus thrombosis secondary prevention
Cerebral venous sinus thrombosis secondary prevention in the news
Blogs on Cerebral venous sinus thrombosis secondary prevention
Directions to Hospitals Treating Cerebral venous sinus thrombosis
Risk calculators and risk factors for Cerebral venous sinus thrombosis secondary prevention

Associate editor in chief: Sharmi Biswas, M.B.B.S

Overview

For patients with cerebral venous thrombosis, a long-term anticoagulant is highly recommended to prevent future events.

Long term anticoagulant should be considered in patients with history of pulmonary thrombosis or deep venous thrombosis.^[1]

↑ van Nuenen, B.F.L.; Munneke, M.; Bloem, B.R. (2005). "Cerebral Venous Sinus Thrombosis: Prevention of Recurrent Thromboembolism". Stroke. 36 (9): 1822–1823. doi:10.1161/01.STR.0000176582.17934.82. ISSN 0039-2499.